Top Bio Functions | Â | Â |
---|---|---|
Diseases and Disorders | Â | Â |
Name | p-value1 | Molecules2 |
Cance r4 | 5.82E-08-.93E-03 | 51 |
Cardiovascular Disease 4 | 2.61E-06-7.93E-03 | 19 |
Developmental Disorder | 2.61E-06-7.93E-03 | 12 |
Hypersensitivity Response | 8.91E-06-7.93E-03 | 8 |
Inflammatory Response | 1.05E-05-7.93E-03 | 25 |
Molecular and Cellular Functions | Â | Â |
Name | p-value | Molecules |
Cell-To-Cell Signaling and Interaction | 1.77E-06-7.93E-03 | 32 |
Cellular Movement | 8.91E-06-7.93E-03 | 25 |
Lipid Metabolism | 9.16E-06-7.93E-03 | 25 |
Molecular Transport | 9.16E-06-7.93E-03 | 28 |
Small Molecule Biochemistry | 9.16E-06-7.93E-03 | 30 |
Physiological System Development and Function | Â | Â |
Name | p-value | Molecules |
Tissue Development | 1.77E-06-7.93E-03 | 24 |
Hematological System Development and Function | 7.13E-06-7.93E-03 | 22 |
Hematopoiesis | 8.91E-06-7.93E-03 | 9 |
Immune Cell Trafficking | 8.91E-06-7.93E-03 | 19 |
Skeletal and Muscular System Development and Function | 2.68E-05-7.93E-03 | 18 |
Top Canonical Pathways | Â | Â |
Name | p-value | Ratio 3 |
Acute Phase Response Signaling | 2.2E-03 | 6/178 (0.034) |
Glycolysis/Gluconeogenesis | 7.65E-03 | 4/142 (0.028) |
N-Glycan Biosynthesis | 9.44E-03 | 3/93 (0.032) |
Calcium Signaling | 1.17E-02 | 5/204 (0.025) |
CXCR4 Signaling | 3.31-02 | 4/169 (0.024) |